Abstract
Undergoing cancer treatment can be traumatic, difficult and time-consuming for patients, and there are inequities in cancer treatment in the current healthcare system.
CtDNA technology is a ground-breaking method of testing and monitoring cancer treatment progress that uses simple blood tests to identify and measure cancer markers in the bloodstream, and has the potential to change how cancer is managed.
The Healthier Lives ctDNA project has established that the use of ctDNA technology in the New Zealand healthcare system will enable timelier and less invasive testing and monitoring of cancer treatment, and could contribute to better outcomes and improved equity.
CtDNA technology has important implications for the health system in the form of reducing inequities, improving access and reducing costs.